Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae0412e72f24b7aea064b1505c6cc11c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2019-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea05994a4b067c19b950658c2f541ad7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f4364c0cf5523f83502c51f1758ff97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed177dc8c3e3aa27c1d1c78e3c72126 |
publicationDate |
2021-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3891282-A1 |
titleOfInvention |
Antisense oligonucleotides rescue aberrant splicing of abca4 |
abstract |
The present invention relates to the field of medicine. In particular, it relates tonovel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Stargardt disease. |
priorityDate |
2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |